The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
Abstract
Amyloid β protein (AβP) is the major constituent of senile plaques associated with Alzheimer's disease (AD). However, its mechanistic role in AD pathogenesis is poorly understood. Globular and non‐fibrillar AβPs are continuously released during normal metabolism. Using techniques of atomic force microscopy, laser confocal microscopy, electrical recording, and biochemical assays, we have examined the molecular conformations of reconstituted globular AβPs as well as their real‐time and acute effects on neuritic degeneration. Atomic force microscopy (AFM) of AβP 1–42 shows globular structures that do not form fibers in physiological‐buffered solution for up to 8 h of continuous imaging. AFM of AβP 1–42 reconstituted in a planar lipid bilayer reveals multimeric channel‐like structures. Consistent with these AFM resolved channel‐like structures, biochemical analysis demonstrates that predominantly monomeric AβPs in solution form stable tetramers and hexamers after incorporation into lipid membranes. Electrophysiological recordings demonstrate the presence of multiple single channel currents of different sizes. At the cellular level, AβP 1–42 allows calcium uptake and induces neuritic abnormality in a dose‐ and time‐dependent fashion. At physiological nanomolar concentrations, rapid neuritic degeneration was observed within minutes;at micromolar concentrations, neuronal death was observed within 3–4 h. These effects are prevented by zinc (an AβP channel blocker) and by the removal of extracellular calcium, but are not prevented by antagonists of putative AβP cell surface receptors. Thus, AβP channels may provide a direct pathway for calcium‐dependent AβP toxicity in AD.—Lin, H., Bhatia, R., Lal, R. Amyloid β‐protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J . 15, 2433–2444 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006 · cited 1×
“The major component of AD senile plaques is a 39–43 residue peptide, the amyloid b protein (AbP), which is the product of proteolytic processing of widely distributed b-amyloid precursor protein (bAPP) (1).”
Backgroundβ-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Arispe, N., Pollard, H. B., & Rojas, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10573 · Cited by 557
Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s2 · Cited by 519
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
Biological applications of atomic force microscopy
Lal, R., & John, S. A. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.1.c1 · Cited by 402
Self-citationKurochkin, I. V., & Goto, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00387-4 · Cited by 340
Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma
Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., & Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32916 · Cited by 331
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.
Arispe, N., Pollard, H. B., & Rojas, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1710 · Cited by 256
Bhatia, R., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1233 · Cited by 226
Self-citationKawahara, M., & Kuroda, Y. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00370-1 · Cited by 224
Ghersi‐Egea, J. ‐., Gorevic, P. D., Ghiso, J., Frangione, B., Patlak, C. S., & Fenstermacher, J. D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020880.x · Cited by 222
Kawahara, M., Arispe, N., Kuroda, Y., & Rojas, E. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78048-2 · Cited by 219
Jensen, M., Schr�der, J., Blomberg, M., Engvall, B., Pantel, J., Ida, N., Basun, H., Wahlund, L.-O., Werle, E., Jauss, M., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9 · Cited by 214
Structural studies of soluble oligomers of the alzheimer β-amyloid peptide
Huang, T. H. J., Yang, D.-S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3559 · Cited by 212
Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity
Pallitto, M. M., Ghanta, J., Heinzelman, P., Kiessling, L. L., & Murphy, R. M. (1999) · Biochemistry · doi:10.1021/bi982119e · Cited by 210
Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations
Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., & Glabe, C. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21037 · Cited by 204
Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel
Rhee, S. K., Quist, A. P., & Lal, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13379 · Cited by 195
Self-citationTheoretical models of the ion channel structure of amyloid beta-protein
Durell, S. R., Guy, H. R., Arispe, N., Rojas, E., & Pollard, H. B. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80717-9 · Cited by 175
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Lin, H., Zhu, Y. J., & Lal, R. (1999) · Biochemistry · doi:10.1021/bi982997c · Cited by 159
Self-citationProperties of cytotoxic peptide-formed ion channels
Kourie, J. I., & Shorthouse, A. A. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.6.c1063 · Cited by 158
Zhu, Y. J., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1244 · Cited by 153
Self-citationAlzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · PubMed · Cited by 151
Blood-Brain Barrier Transport of Circulating Alzheimer′s Amyloid β
Zlokovic, B. V., Ghiso, J., Mackic, J. B., Mccomb, J. G., Weiss, M. H., & Frangione, B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2582 · Cited by 150
Alzheimer amyloid aβ1-42 channels: Effects of solvent, pH, and congo red
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4<458::aid-jnr5>3.0.co;2-4 · Cited by 143
Pillot, T., Drouet, B., Queillé, S., Labeur, C., Vandekerckhove, J. S., Rosseneu, M., Pinçon‐Raymond, M., & Chambaz, J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731626.x · Cited by 134
Mason, R. P., Jacob, R. F., Walter, M. F., Mason, P. E., Avdulov, N. A., Chochina, S. V., Igbavboa, U., & Wood, W. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18801 · Cited by 123
Tseng, B. P., Esler, W. P., Clish, C. B., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., Lee, J. P., & Maggio, J. E. (1999) · Biochemistry · doi:10.1021/bi990718v · Cited by 119
Dendritic changes in Alzheimer's disease and factors that may underlie these changes
Anderton, B. H., Callahan, L. M., Coleman, P. D., Davies, P., Flood, D. G., Jicha, G. A., Ohm, T. G., & Weaver, C. L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00022-7 · Cited by 113
Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer's Amyloid-β Peptide Degradation
Yamin, R., Malgeri, E. G., Sloane, J. A., McGraw, W. T., & Abraham, C. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18777 · Cited by 88
Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
Poduslo, J. F., Curran, G. L., Sanyal, B., & Selkoe, D. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0238 · Cited by 85
Amyloid β peptides act directly on single neurons
Simmons, M. A., & Schneider, C. R. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90519-q · Cited by 85
Imaging real-time aggregation of amyloid beta protein (1–42) by atomic force microscopy
Parbhu, A. N., Lin, H., Thimm, J. C., & Lal, R. (2002) · Peptides · doi:10.1016/s0196-9781(02)00061-x · Cited by 77
Self-citationHarkany, T., Mulder, J., Sasvári, M., Ábrahám, I. M., Kónya, C., Zarándi, M., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0230 · Cited by 72
Sanderson, K. L., Butler, L. D., & Ingram, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01060-8 · Cited by 67
Huang, H., Ou, H., Hsieh, S., & Chiang, L.-Y. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00470-7 · Cited by 61
Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade
Whitson, J. S., & Appel, S. H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80002-9 · Cited by 41
β-Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells
Naidu, A., Quon, D. H., & Cordell, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1369 · Cited by 40
Vargas, J., Alarcón, J. M., & Rojas, E. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76348-x · Cited by 39
Torp, R., Head, E., & Cotman, C. W. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00107-x · Cited by 37
Cited by
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Metadata
- Authors
- LIN, H., BHATIA, R., & LAL, R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-11
- Volume
- 15
- Issue
- 13
- Pages
- 2433-2444
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2075930760
- Cited by
- 644
- References
- 51
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.